|
WDR53 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.9475983006414E-13 |
| Normal-vs-Stage2 |
1.00139999958948E-07 |
| Normal-vs-Stage3 |
2.40008013463466E-12 |
| Normal-vs-Stage4 |
1.6574519534629E-12 |
| Stage1-vs-Stage2 |
6.695400E-01 |
| Stage1-vs-Stage3 |
5.636200E-02 |
| Stage1-vs-Stage4 |
4.770700E-04 |
| Stage2-vs-Stage3 |
3.972200E-01 |
| Stage2-vs-Stage4 |
2.107500E-02 |
| Stage3-vs-Stage4 |
8.060200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.99520433297585E-15 |
| Normal-vs-AfricanAmerican |
1.07009999972263E-07 |
| Normal-vs-Asian |
1.75376999999033E-05 |
| Caucasian-vs-AfricanAmerican |
3.855600E-01 |
| Caucasian-vs-Asian |
7.054200E-02 |
| AfricanAmerican-vs-Asian |
5.869800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.88418203051333E-15 |
| Normal-vs-Female |
1.68220992691204E-12 |
| Male-vs-Female |
3.982000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.19180221247461E-11 |
| Normal-vs-Age(41-60Yrs) |
2.58237875527811E-13 |
| Normal-vs-Age(61-80Yrs) |
1.64757096854373E-12 |
| Normal-vs-Age(81-100Yrs) |
1.904180E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.983600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.697700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.973800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.231420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.508400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.399600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.520330E-02 |
| Classical-VS-Follicular |
6.460300E-03 |
| Classical-VS-Other |
5.902800E-01 |
| Classical-VS-Normal |
4.87954121553003E-12 |
| Tall-VS-Follicular |
5.729800E-01 |
| Tall-VS-Other |
5.007400E-01 |
| Tall-VS-Normal |
2.05600003688744E-09 |
| Follicular-VS-Other |
7.295800E-01 |
| Follicular-VS-Normal |
4.1625591862271E-12 |
| Other-VS-Normal |
4.464300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.13310472116268E-11 |
| Normal-vs-N1 |
6.64429955499202E-10 |
| N0-vs-N1 |
6.296600E-01 |
|
|
